A detailed history of Td Asset Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 2,506,547 shares of MRK stock, worth $244 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,506,547
Previous 5,190,353 51.71%
Holding current value
$244 Million
Previous $643 Million 55.7%
% of portfolio
0.27%
Previous 0.63%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$111.15 - $128.97 $298 Million - $346 Million
-2,683,806 Reduced 51.71%
2,506,547 $285 Million
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $3.1 Million - $3.33 Million
25,038 Added 0.48%
5,190,353 $643 Million
Q1 2024

May 08, 2024

SELL
$113.24 - $131.95 $25.2 Million - $29.4 Million
-222,509 Reduced 4.13%
5,165,315 $682 Million
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $36.1 Million - $39.3 Million
360,688 Added 7.17%
5,387,824 $587 Million
Q3 2023

Oct 27, 2023

BUY
$102.95 - $114.33 $7.64 Million - $8.48 Million
74,194 Added 1.5%
5,027,136 $518 Million
Q2 2023

Aug 09, 2023

BUY
$108.61 - $118.38 $9.38 Million - $10.2 Million
86,356 Added 1.77%
4,952,942 $572 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $244 Million - $273 Million
2,374,338 Added 95.27%
4,866,586 $518 Million
Q4 2022

Feb 06, 2023

SELL
$87.44 - $112.11 $12.6 Million - $16.1 Million
-143,556 Reduced 5.45%
2,492,248 $276 Million
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $16.2 Million - $18.2 Million
-191,234 Reduced 6.76%
2,635,804 $228 Million
Q2 2022

Aug 04, 2022

SELL
$83.49 - $94.64 $9.48 Million - $10.7 Million
-113,490 Reduced 3.86%
2,827,038 $258 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $14.1 Million - $15.8 Million
-192,058 Reduced 6.13%
2,940,528 $241 Million
Q4 2021

Feb 10, 2022

SELL
$72.28 - $90.54 $4.04 Million - $5.06 Million
-55,910 Reduced 1.75%
3,132,586 $240 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $9.63 Million - $10.6 Million
134,378 Added 4.4%
3,188,496 $239 Million
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $31.9 Million - $35.3 Million
-454,300 Reduced 12.95%
3,054,118 $235 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $122 Million - $143 Million
-1,766,305 Reduced 33.49%
3,508,418 $270 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $9.21 Million - $10.2 Million
-128,292 Reduced 2.37%
5,274,723 $431 Million
Q3 2020

Nov 10, 2020

SELL
$73.18 - $82.95 $1.01 Million - $1.15 Million
-13,817 Reduced 0.26%
5,403,015 $448 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $66.3 Million - $75.4 Million
940,851 Added 21.02%
5,416,832 $419 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $8.13 Million - $11.3 Million
128,266 Added 2.95%
4,475,981 $344 Million
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $17.6 Million - $19.8 Million
226,573 Added 5.5%
4,347,715 $395 Million
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $48.3 Million - $52.7 Million
634,958 Added 18.21%
4,121,142 $347 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $24.3 Million - $28.4 Million
348,378 Added 11.1%
3,486,184 $292 Million
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $17.9 Million - $20.4 Million
257,435 Added 8.94%
3,137,806 $261 Million
Q4 2018

Feb 01, 2019

BUY
$65.24 - $75.71 $17.4 Million - $20.2 Million
267,300 Added 10.23%
2,880,371 $220 Million
Q3 2018

Nov 01, 2018

SELL
$57.69 - $67.84 $5.81 Million - $6.83 Million
-100,730 Reduced 3.71%
2,613,071 $185 Million
Q2 2018

Jul 31, 2018

BUY
$50.83 - $59.72 $8.38 Million - $9.85 Million
164,948 Added 6.47%
2,713,801 $165 Million
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $1.91 Million - $2.22 Million
-37,534 Reduced 1.45%
2,548,853 $139 Million
Q4 2017

Feb 02, 2018

BUY
$51.62 - $61.64 $1.05 Million - $1.25 Million
20,350 Added 0.79%
2,586,387 $146 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $151 Million - $162 Million
2,566,037
2,566,037 $164 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.